HCPCS Code A4232: Syringe with needle for external insulin pump

Key Takeaways

HCPCS code A4232 describes a sterile 3cc syringe with needle for use with an external insulin pump, falling under Injection and Infusion Supplies (A4206-A4232)

A4232 carries a CMS Medicare coverage status of ‘I’ (not payable) and CMS’s External Infusion Pumps Policy Article (A52507) states it is invalid for submission to Medicare — it should never be billed to Original Medicare

A4232 is instead reimbursed by state Medicaid programs (for example, New York Medicaid/eMedNY pays $3.57 per syringe, up to 30 units per two-month supply) and by some commercial payers as a diabetic-supply code

Practice management software like Pabau can track claim status and keep supporting documentation organized, helping practices and suppliers catch a misrouted claim before it reaches a payer that will never pay it

HCPCS code A4232 describes a sterile syringe with needle made specifically for use with an external insulin pump. It’s a narrow, single-purpose code, but it sits at the center of a coding mistake that’s more common than it should be: billing it to a payer that will never pay it.

Original Medicare does not pay for A4232. CMS assigns the code a Medicare coverage status of “I” — invalid, not payable — and its own External Infusion Pumps Policy Article states plainly that A4232 is invalid for submission to Medicare.

The suppliers and practices that get reimbursed for this code bill it to state Medicaid programs or commercial payers, not to a Medicare DME MAC.

HCPCS Code A4232: Clinical description

HCPCS Code A4232 covers a sterile syringe with needle designed specifically for use with an external insulin pump. It belongs to the Injection and Infusion Supplies category of the HCPCS Level II system, maintained by the Centers for Medicare and Medicaid Services (CMS).

Despite sitting inside the same code system CMS uses for Medicare billing, A4232 itself is not a Medicare-payable code (see the coverage section below) — coders and suppliers use it to bill state Medicaid programs and commercial payers for insulin pump syringe refills supplied to diabetic patients.

The full official description is: Syringe with needle for external insulin pump, sterile. The syringe capacity is 3cc. Billing A4232 outside this specific device context, or for standard (non-pump) insulin syringes, is a coding error that triggers denials.

A4232 code details at a glance

Use the table below as a quick reference before billing or verifying a claim. Every field maps to a CMS-defined attribute of HCPCS Code A4232.

Coverage and eligibility for A4232

Original Medicare does not cover HCPCS Code A4232. CMS assigns the code a Medicare coverage status of “I,” meaning it is not payable, and its External Infusion Pumps Policy Article (A52507) states that A4232 is invalid for submission to Medicare and should not be used for that purpose.

No Local Coverage Determination, KX modifier, or Certificate of Medical Necessity changes that outcome — the code simply isn’t part of the Medicare DME benefit.

When Medicare does cover insulin pump supplies, it uses a different code set entirely. Code A4224 is the all-inclusive code for external insulin infusion pump supplies (cannulas, needles, dressings, and infusion supplies), billed alongside A4225 for the insulin reservoir or cartridge.

K0552 is sometimes assumed to be the insulin pump reservoir code, but it applies only to non-insulin external infusion pumps (E0779, E0780, E0781, E0791, or K0455) and should not be confused with insulin pump billing under A4224/A4225.

Coverage for A4232 itself comes from other payers:

• State Medicaid programs: New York Medicaid, for example, covers A4232 through its eMedNY program. Effective November 1, 2021, eMedNY’s updated billing guidelines added A4232 to its DMEPOS fee schedule at $3.57 per syringe, with a maximum of 30 units (a two-month supply). Other state Medicaid programs may cover the code under different rates, quantity limits, and documentation thresholds, so always check the applicable state Medicaid manual before billing.
• Commercial payers: Some commercial health plans reimburse A4232 as a diabetic-supply benefit, subject to plan-specific medical necessity, prior authorization, and quantity rules.

Baseline documentation requirements that apply across state Medicaid programs and commercial payers include a current physician order or prescription, clinical documentation supporting the diabetes diagnosis and pump use, and supplier enrollment or network participation with the specific paying entity. Some payers also require prior authorization before the quantity limit can be exceeded.

DME and pharmacy supplier enrollment requirement

Only suppliers enrolled with, or participating in the network of, the payer that will reimburse the claim may bill A4232. New York Medicaid, for example, allows the item to be dispensed by DME providers (Category of Service 0321) as well as pharmacy providers (Category of Service 0441 or 0442).

Because Original Medicare does not pay this code, Medicare DME enrollment alone does not create a payment pathway — suppliers need enrollment or network status with the specific state Medicaid program or commercial payer instead.

2026 Fee schedule and reimbursement rates for A4232

Because Original Medicare does not cover A4232, there is no Medicare DMEPOS fee-schedule allowable to reference for this code. Reimbursement is instead set by whichever payer covers the claim — a state Medicaid program or a commercial payer — and rates vary accordingly.

New York Medicaid’s eMedNY program, for example, reimburses A4232 at $3.57 per syringe, with a maximum of 30 units per two-month supply. That rate and quantity limit have applied since November 1, 2021, when eMedNY added A4232 to its DMEPOS fee schedule and opened billing to both DME providers and pharmacy providers.

Other state Medicaid programs and commercial payers set their own rates and quantity caps, so always confirm the current figure with the specific paying entity before billing.

Rates published on third-party sites may be outdated, or may reflect a Medicare DMEPOS figure that doesn’t apply to this code. Always confirm the current allowable and quantity limit directly with the specific paying Medicaid program or commercial payer before quoting a reimbursement figure to a patient.

Billing guidelines for HCPCS Code A4232

Accurate billing for A4232 starts with routing the claim to the correct payer and constructing it correctly for that payer. Suppliers billing this code should use claims management software that tracks claim status and keeps the physician order, diagnosis, and delivery record linked to each submission. The core billing requirements are:

• Claim form: CMS-1500 (or its 837P electronic equivalent) for professional claims
• Place of service: Home (12) when supplies are used at the patient’s residence
• Units of service: Bill per syringe supplied; units must match the quantity dispensed, the physician order, and the paying payer’s quantity limit (for example, NY Medicaid/eMedNY caps A4232 at 30 units per two-month supply)
• Diagnosis code: Pair with the appropriate ICD-10-CM code for the patient’s diabetes diagnosis (e.g. E11.649 for Type 2 diabetes with hypoglycemia)
• Physician order or prescription: A signed, dated order supporting the supply and quantity dispensed must be on file. Medicare’s old Certificate of Medical Necessity (CMN) process does not apply here, both because A4232 is not billed to Medicare and because CMS eliminated CMNs for Medicare DME generally for dates of service on or after January 1, 2023

Maintaining HIPAA-compliant billing workflows protects your practice during payer audits. Every A4232 claim should be traceable back to a dated physician order without requiring manual file searches.

Modifiers and A4232

Unlike Medicare DME claims, A4232 claims don’t use the KX/GA/GY/GZ modifier framework. That framework exists specifically to signal Local Coverage Determination compliance on Medicare DME claims, and A4232 is never submitted to Medicare.

State Medicaid programs and commercial payers may have their own modifier conventions for diabetic supplies, but there is no equivalent national modifier requirement for A4232. Check the specific payer’s billing manual before assuming a modifier applies.

Streamline your practice’s claims and billing workflows

Pabau's claims management software helps practices track claims, store supporting documentation, and reduce the manual errors that slow down reimbursement, all from one system alongside patient records and scheduling.

Book a demo

Documentation requirements for A4232

Inadequate documentation is the leading reason A4232 claims fail post-payment audit. This is especially true for metabolic health practices and weight-loss practices managing patients on insulin pumps, where supply refills recur every billing cycle.

Every claim must be supported by records that independently prove medical necessity to the paying Medicaid program or commercial payer, without relying on the biller’s notes. Good medical intake forms provide a consistent structure for capturing this documentation at intake and throughout the patient’s care.

Required documentation for each A4232 claim includes:

• Physician order or prescription: A signed, dated order specifying the syringe supply, quantity, and refill frequency
• Proof of delivery: Signed delivery confirmation from the patient or authorized representative, with date and items received
• Diabetes diagnosis documentation: Supporting clinical notes confirming the patient’s diabetes type and insulin pump use
• Prior authorization (where required): Some state Medicaid programs and commercial payers require prior authorization before supplying A4232 items, and most enforce a quantity limit (for example, NY Medicaid/eMedNY’s 30 units per two-month supply) that a prescriber must justify exceeding
• Supplier enrollment: Evidence of valid enrollment or network participation with the specific paying Medicaid program or commercial payer at the time of service

Store all documentation in digital forms that are timestamped and audit-ready. Paper records that cannot be retrieved quickly during a payer audit put reimbursement at risk. Keeping HIPAA compliance top of mind when storing patient records protects both the patient and the practice.

ICD-10 diagnosis codes used with A4232

A4232 is a supply code, so state Medicaid programs and commercial payers require it to be billed alongside an ICD-10-CM diagnosis code establishing that the patient’s diabetes management requires an external insulin pump.

• E10.- (Type 1 diabetes mellitus) codes, commonly paired with Z79.4 to document long-term insulin use
• E11.- (Type 2 diabetes mellitus) codes, such as E11.649 (Type 2 diabetes with hypoglycemia), where the treatment plan includes an external insulin pump
• Z79.4 (long-term current use of insulin), typically listed alongside the primary diabetes diagnosis to support ongoing pump-supply claims

Always confirm the specific ICD-10 code and any state-specific coding requirements against the paying Medicaid program’s or commercial payer’s current policy before submission.

Related HCPCS codes in the A4206-A4232 range

The Injection and Infusion Supplies category spans codes A4206 through A4232. Selecting the correct code within this range requires matching the specific supply to its descriptor. Using A4232 when a different supply code applies is a coding error that creates overpayment liability.

The same logic applies to nearby supply codes such as A4356 and Q5114, where billing the wrong item on an otherwise correct claim is one of the most common causes of denial.

Common billing errors and claim denials for A4232

Most A4232 denials trace back to a handful of preventable errors, starting with the most basic one: billing the wrong payer entirely. Reviewing claims against this checklist before submission catches the majority of them.

• Submitting to Medicare: A4232 carries CMS Medicare coverage status “I” and is invalid for Medicare submission. Practices that inherited billing workflows built around Medicare DME rules for this code will see automatic rejections. Route the claim to the patient’s state Medicaid program or commercial payer instead.
• Incorrect units: Billing 1 unit when 10 syringes were dispensed, or exceeding the paying payer’s quantity limit (for example, NY Medicaid/eMedNY’s 30 units per two-month supply) without prior authorization, triggers denials or post-payment audits. Units must match both the delivery record and the physician order.
• Missing physician order: A claim without a current, signed, dated physician order or prescription on file will be denied on audit. There is no Certificate of Medical Necessity fallback for this code — the order itself is the required documentation.
• Wrong code for supply type: Using A4232 for a standard (non-pump) 3cc syringe (which would correctly use A4208) constitutes a coding error. The code descriptor explicitly requires the syringe to be for an external insulin pump.
• Non-enrolled or out-of-network supplier: Billing a state Medicaid program or commercial payer for A4232 without active enrollment or network participation results in full claim rejection, not just denial.

Using HIPAA-compliant billing software for your billing records also reduces the risk of missing documentation surfacing during payer audits. Secure, well-organized records are the first line of defense in any compliance review. Practices that maintain patient data security tools alongside compliant billing workflows are better positioned when a Medicaid or commercial payer review is initiated.

How billing software can streamline A4232 claims

Billing A4232 correctly means catching a payer-routing mistake or a missing document before a claim goes out, not after it’s denied. Manual, spreadsheet-based tracking makes both easy to miss at scale.

Pabau keeps the patient record, physician order, and claim status together in one system, making it easier to catch a missing document or a misrouted claim before submission. Practices moving toward a paperless, HIPAA-compliant practice can store physician orders and delivery records digitally, making audit retrieval faster.

For practices managing prescription management software alongside supply billing, integration between prescription records and HCPCS claims eliminates duplicate data entry. Strong EHR integration ensures the diagnosis codes tied to each A4232 claim reflect the most current clinical documentation, reducing medical-necessity denials.

Conclusion

HCPCS Code A4232 claims fail for one predictable reason above all others: billing the wrong payer. Original Medicare does not cover this code — CMS assigns it coverage status “I,” and its External Infusion Pumps Policy Article confirms it’s invalid for Medicare submission.

The suppliers who get reimbursed bill state Medicaid programs, like New York’s eMedNY, or commercial payers instead, with a current physician order, the correct diagnosis code, and quantities that stay within that payer’s limit.

Pabau connects the patient’s physician order, diagnosis, and claim status in one auditable record, reducing the manual steps that introduce errors. If your billing workflow relies on spreadsheets and manual payer lookups, book a demo to see how Pabau can help.

Continue your research

Billing a plain needle instead of a pump syringe? Our A4215 guide covers the sterile needle code and how it differs from pump-specific supply codes.

Billing an injectable drug alongside a supply code? The J3300 guide walks through billing triamcinolone acetonide injections.

Need a per diem HCPCS code for a rehab program? See our H2001 guide for billing rules on half-day rehabilitation services.

Pairing a cardiac diagnosis with a supply claim? Our I51.5 guide covers billing for myocardial degeneration.

Billing a UK private patient instead? The 0080S guide covers CCSD billing rules and insurer guidance for a different procedure.

Frequently asked questions